Article
Dihydropyrimidinones and -thiones with improved activity against human polyomavirus family members
31 Aug 2016
Abstract excerpt
Human polyomaviruses are generally latent but can be reactivated in patients whose immune systems are suppressed. Unfortunately, current therapeutics for diseases associated with polyomaviruses are non-specific, have undefined mechanisms of action, or exacerbate the disease. We previously reported on a class of dihydropyrimidinones that specifically target a polyomavirus-encoded protein, T antigen, and/or inhibit...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
